See more : Freeze Tag, Inc. (FRZT) Income Statement Analysis – Financial Results
Complete financial analysis of Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chongqing Lummy Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Dongguan Aohai Technology Co., Ltd. (002993.SZ) Income Statement Analysis – Financial Results
- Enzon Pharmaceuticals, Inc. (ENZN) Income Statement Analysis – Financial Results
- NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO) Income Statement Analysis – Financial Results
- Fastenal Company (FAST) Income Statement Analysis – Financial Results
- Adeunis Société anonyme (ALARF.PA) Income Statement Analysis – Financial Results
Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
About Chongqing Lummy Pharmaceutical Co., Ltd.
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 895.59M | 884.59M | 1.23B | 1.58B | 1.86B | 1.56B | 1.28B | 990.22M | 963.98M | 911.80M | 759.12M | 631.46M | 534.09M | 377.65M | 333.54M | 265.22M | 166.06M | 96.47M |
| Cost of Revenue | 283.15M | 234.44M | 349.60M | 505.32M | 524.94M | 612.51M | 655.88M | 576.12M | 606.59M | 620.47M | 470.68M | 379.21M | 334.22M | 239.62M | 212.51M | 169.46M | 106.23M | 56.51M |
| Gross Profit | 612.44M | 650.15M | 875.62M | 1.08B | 1.33B | 949.86M | 626.20M | 414.10M | 357.38M | 291.34M | 288.43M | 252.26M | 199.87M | 138.03M | 121.04M | 95.76M | 59.82M | 39.96M |
| Gross Profit Ratio | 68.38% | 73.50% | 71.47% | 68.09% | 71.76% | 60.80% | 48.84% | 41.82% | 37.07% | 31.95% | 38.00% | 39.95% | 37.42% | 36.55% | 36.29% | 36.11% | 36.02% | 41.42% |
| Research & Development | 93.59M | 80.65M | 100.20M | 107.36M | 164.04M | 42.74M | 31.88M | 31.25M | 33.74M | 27.31M | 18.37M | 15.63M | 16.31M | 24.17M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 46.56M | 39.90M | 51.67M | 66.88M | 35.58M | 22.56M | 20.55M | 25.67M | 21.40M | 24.98M | 20.08M | 12.33M | 11.80M | 7.90M | 35.37M | 25.91M | 12.90M | 16.63M |
| Selling & Marketing | 416.67M | 530.02M | 714.43M | 841.31M | 952.36M | 602.23M | 341.19M | 124.96M | 100.86M | 93.64M | 89.94M | 95.12M | 50.90M | 36.68M | 32.72M | 27.32M | 16.14M | 10.37M |
| SG&A | 463.23M | 569.93M | 766.10M | 908.19M | 987.94M | 624.79M | 361.74M | 150.63M | 122.26M | 118.61M | 110.01M | 107.44M | 62.70M | 44.59M | 68.09M | 53.23M | 29.04M | 27.00M |
| Other Expenses | -4.87M | 20.79M | -35.82M | 2.49M | -786.10K | -196.15K | -413.02K | 13.48M | 11.35M | 6.72M | 25.27M | 34.55M | 21.28M | 3.16M | 3.68M | 1.72M | 511.47K | 315.78K |
| Operating Expenses | 564.69M | 705.69M | 922.70M | 1.10B | 1.25B | 787.75M | 529.78M | 321.02M | 259.88M | 236.14M | 204.60M | 171.02M | 118.62M | 89.12M | 70.16M | 54.75M | 30.07M | 27.84M |
| Cost & Expenses | 839.37M | 940.12M | 1.27B | 1.61B | 1.77B | 1.40B | 1.19B | 897.14M | 866.47M | 856.61M | 675.29M | 550.23M | 452.84M | 328.75M | 282.67M | 224.21M | 136.30M | 84.35M |
| Interest Income | 34.64M | 12.93M | 13.53M | 6.36M | 4.34M | 2.05M | 1.74M | 2.15M | 2.52M | 4.68M | 6.82M | 2.19M | 2.96M | 4.20M | 564.46K | -0.53 | -0.33 | -0.02 |
| Interest Expense | 12.59M | 20.35M | 32.08M | 83.19M | 72.33M | 57.88M | 36.87M | 31.36M | 52.92M | 41.41M | 32.62M | 22.47M | 14.20M | 4.22M | 4.24M | 4.75M | 2.33M | 1.05M |
| Depreciation & Amortization | 75.42M | 78.19M | 75.59M | 110.37M | 109.50M | 108.85M | 112.83M | 110.81M | 105.41M | 79.86M | 51.10M | 31.55M | 22.94M | 9.81M | 7.53M | 6.17M | 4.16M | 6.74M |
| EBITDA | 116.49M | 19.47M | -1.19M | -148.58M | 34.52M | 281.57M | 179.70M | 144.74M | 183.25M | 127.62M | 160.60M | 118.56M | 125.25M | 64.90M | 60.25M | 47.18M | 33.91M | 18.87M |
| EBITDA Ratio | 13.01% | 7.12% | 4.27% | 5.56% | 9.94% | 19.65% | 17.59% | 22.52% | 21.51% | 15.00% | 21.33% | 19.07% | 23.78% | 17.42% | 18.35% | 18.20% | 19.13% | 21.78% |
| Operating Income | 56.23M | -96.04M | -70.14M | -346.09M | -168.93M | 109.50M | 48.30M | -3.92M | 16.53M | 4.74M | 49.83M | 53.46M | 66.04M | 47.54M | 45.07M | 35.18M | 29.56M | 8.93M |
| Operating Income Ratio | 6.28% | -10.86% | -5.72% | -21.86% | -9.09% | 7.01% | 3.77% | -0.40% | 1.71% | 0.52% | 6.56% | 8.47% | 12.36% | 12.59% | 13.51% | 13.26% | 17.80% | 9.26% |
| Total Other Income/Expenses | -52.63M | 20.79M | -35.82M | -228.42M | -179.08M | 3.19M | -29.60M | -65.13M | -51.43M | -44.93M | 25.21M | -14.86M | 20.91M | 2.97M | 3.31M | 1.72M | 511.47K | 315.78K |
| Income Before Tax | 3.59M | -75.25M | -105.96M | -343.60M | -169.72M | 109.30M | 47.89M | 4.02M | 24.91M | 6.34M | 75.04M | 63.28M | 86.95M | 50.51M | 48.37M | 36.90M | 30.07M | 9.25M |
| Income Before Tax Ratio | 0.40% | -8.51% | -8.65% | -21.70% | -9.13% | 7.00% | 3.74% | 0.41% | 2.58% | 0.70% | 9.88% | 10.02% | 16.28% | 13.37% | 14.50% | 13.91% | 18.11% | 9.58% |
| Income Tax Expense | 13.61M | 1.04M | -27.42K | 1.05M | -8.33M | 18.17M | 1.82M | 2.76M | 4.51M | -4.92M | 11.89M | 8.15M | 12.30M | 6.69M | 7.91M | 4.01M | 5.45M | -600.85K |
| Net Income | -8.93M | -68.71M | -100.53M | -326.76M | -155.20M | 98.00M | 55.56M | 6.98M | 20.61M | 9.28M | 60.81M | 53.71M | 73.09M | 43.87M | 40.47M | 32.89M | 24.49M | 8.54M |
| Net Income Ratio | -1.00% | -7.77% | -8.20% | -20.64% | -8.35% | 6.27% | 4.33% | 0.71% | 2.14% | 1.02% | 8.01% | 8.51% | 13.68% | 11.62% | 12.13% | 12.40% | 14.75% | 8.86% |
| EPS | -0.01 | -0.07 | -0.10 | -0.40 | -0.19 | 0.12 | 0.07 | 0.01 | 0.03 | 0.01 | 0.09 | 0.08 | 0.11 | 0.07 | 0.08 | 0.07 | 0.08 | 0.05 |
| EPS Diluted | -0.01 | -0.07 | -0.10 | -0.40 | -0.19 | 0.12 | 0.07 | 0.01 | 0.03 | 0.01 | 0.09 | 0.08 | 0.11 | 0.07 | 0.08 | 0.07 | 0.08 | 0.05 |
| Weighted Avg Shares Out | 1.05B | 1.06B | 995.33M | 812.24M | 812.24M | 811.96M | 812.24M | 775.68M | 687.08M | 668.06M | 684.10M | 666.77M | 657.81M | 658.03M | 529.76M | 493.30M | 309.39M | 180.92M |
| Weighted Avg Shares Out (Dil) | 1.05B | 1.06B | 995.33M | 812.24M | 812.24M | 811.96M | 817.08M | 775.68M | 687.08M | 668.06M | 684.10M | 666.77M | 657.81M | 658.03M | 529.76M | 493.30M | 309.39M | 180.92M |
Source: https://incomestatements.info
Category: Stock Reports